Does Oxcarbazepine Warrant Therapeutic Drug Monitoring?: A Critical Review

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.12, 2008-01, pp. : 767-778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?

By Schwenger Erin Dumontet Jane Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite

Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?

By Perucca E.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 191-204

Adis International

Access to resources Recommend Favorite

Pharmacogenetics: The Therapeutic Drug Monitoring of the Future?

By Ensom M.H.H.

Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. : 783-802

Adis International

Access to resources Recommend Favorite

Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen Ensom Mary H.H.

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite